Roche, AstraZeneca help European shares start June on high note
LONDON, June 1 (Reuters) - European shares kicked off June on a positive note on Monday, helped by a rise in pharma stocks, although main indexes were still stuck in their recent range as uncertainty persisted over Greece's future.
AstraZeneca and Roche, both up more 2 percent, led a rise in the healthcare sector after each published a positive update on one of their anti-cancer drugs.
They were the top risers on the pan-European FTSEurofirst 300 index, which was up 0.6 percent after shedding 2 percent the previous week.
Athens and its euro zone and International Monetary Fund (IMF) creditors have been locked in talks for months on a cash-for-reforms agreement. Athens faces a payment to the IMF on June 5 as well as the expiration of its bailout programme on June 30.
"We were short at the end of last week but we're neutral now," Markus Huber, senior trader at Peregrine & Black, said.
"Greece may not get a deal last week but they will probably make the (IMF) payment."
Investors were awaiting May manufacturing data from major euro zone countries and the currency bloc as a whole between 0745 GMT and 0800 GMT. Monthly German inflation data, which helped spark a selloff in bonds in May, was due at 1200 GMT. (Reporting by Francesco Canepa; Editing by Sudip Kar-Gupta)
© Thomson Reuters 2017 All rights reserved.